{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T08:36:04Z","timestamp":1788683764272,"version":"build-2803163510"},"reference-count":41,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T00:00:00Z","timestamp":1667520000000},"content-version":"vor","delay-in-days":1648,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL057530"],"award-info":[{"award-number":["HL057530"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI085268"],"award-info":[{"award-number":["AI085268"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1T32HL098049"],"award-info":[{"award-number":["1T32HL098049"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1111\/jth.13964","type":"journal-article","created":{"date-parts":[[2018,1,31]],"date-time":"2018-01-31T08:16:11Z","timestamp":1517386571000},"page":"991-1002","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Carboxypeptidase B2 and N play different roles in regulation of activated complements C3a and C5a in mice"],"prefix":"10.1016","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3376-8692","authenticated-orcid":false,"given":"J.","family":"Morser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q.","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Higgins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.L.K.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/jth.13964_bb0010","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1111\/j.1538-7836.2009.03596.x","article-title":"Carboxypeptidase U (TAFIa): a new drug target for fibrinolytic therapy?","volume":"7","author":"Willemse","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13964_bb0015","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1111\/jth.13396","article-title":"Structure\u2010function relationships in thrombin\u2010activatable fibrinolysis inhibitor: comment","volume":"14","author":"Gurewich","year":"2016","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13964_bb0020","doi-asserted-by":"crossref","first-page":"35046","DOI":"10.1074\/jbc.274.49.35046","article-title":"Characterization of plasmin\u2010mediated activation of plasma procarboxypeptidase B. Modulation by glycosaminoglycans","volume":"274","author":"Mao","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.13964_bb0025","doi-asserted-by":"crossref","first-page":"16603","DOI":"10.1074\/jbc.271.28.16603","article-title":"TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin\u2010thrombomodulin complex","volume":"271","author":"Bajzar","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.13964_bb0030","doi-asserted-by":"crossref","first-page":"51059","DOI":"10.1074\/jbc.M306977200","article-title":"Thrombin activatable fibrinolysis inhibitor, a potential regulator of vascular inflammation","volume":"278","author":"Myles","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.13964_bb0035","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1016\/j.intimp.2007.07.014","article-title":"Structure and function of human plasma carboxypeptidase N, the anaphylatoxin inactivator","volume":"7","author":"Skidgel","year":"2007","journal-title":"Int Immunopharmacol"},{"key":"10.1111\/jth.13964_bb0040","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.1538-7836.2010.03787.x","article-title":"What has been learnt from the thrombin\u2010activatable fibrinolysis inhibitor\u2010deficient mouse?","volume":"8","author":"Morser","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13964_bb0045","doi-asserted-by":"crossref","first-page":"6533","DOI":"10.4049\/jimmunol.0804207","article-title":"Targeted disruption of the gene encoding the murine small subunit of carboxypeptidase N (CPN1) causes susceptibility to C5a anaphylatoxin\u2010mediated shock","volume":"182","author":"Mueller\u2010Ortiz","year":"2009","journal-title":"J Immunol"},{"key":"10.1111\/jth.13964_bb0050","doi-asserted-by":"crossref","first-page":"4669","DOI":"10.4049\/jimmunol.173.7.4669","article-title":"Absence of procarboxypeptidase R induces complement\u2010mediated lethal inflammation in lipopolysaccharide\u2010primed mice","volume":"173","author":"Asai","year":"2004","journal-title":"J Immunol"},{"key":"10.1111\/jth.13964_bb0055","first-page":"3517","article-title":"Plasma carboxypeptidase B downregulates inflammatory responses in autoimmune arthritis","volume":"121","author":"Song","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1111\/jth.13964_bb0060","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/jth.12956","article-title":"Carboxypeptidase B2 deficiency reveals opposite effects of complement C3a and C5a in a murine polymicrobial sepsis model","volume":"13","author":"Shao","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13964_bb0065","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1182\/blood-2006-03-012567","article-title":"Thrombin\u2010activatable procarboxypeptidase B regulates activated complement C5a in vivo","volume":"109","author":"Nishimura","year":"2007","journal-title":"Blood"},{"key":"10.1111\/jth.13964_bb0070","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.2215\/CJN.02730409","article-title":"Alternative pathway of complement in children with diarrhea\u2010associated hemolytic uremic syndrome","volume":"4","author":"Thurman","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1111\/jth.13964_bb0075","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1056\/NEJMc1100859","article-title":"Eculizumab in severe Shiga\u2010toxin\u2010associated HUS","volume":"364","author":"Lapeyraque","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.13964_bb0080","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","article-title":"Terminal complement inhibitor eculizumab in atypical hemolytic\u2010uremic syndrome","volume":"368","author":"Legendre","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.13964_bb0085","doi-asserted-by":"crossref","first-page":"e003573","DOI":"10.1136\/bmjopen-2013-003573","article-title":"A systematic review of eculizumab for atypical haemolytic uraemic syndrome (aHUS)","volume":"3","author":"Rathbone","year":"2013","journal-title":"BMJ Open"},{"key":"10.1111\/jth.13964_bb0090","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.hoc.2015.01.007","article-title":"Shiga toxin associated hemolytic uremic syndrome","volume":"29","author":"Keir","year":"2015","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1111\/jth.13964_bb0095","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1182\/blood-2014-09-600411","article-title":"Eculizumab reduces complement activation, inflammation, endothelial damage, thrombosis, and renal injury markers in aHUS","volume":"125","author":"Cofiell","year":"2015","journal-title":"Blood"},{"key":"10.1111\/jth.13964_bb0100","doi-asserted-by":"crossref","first-page":"172","DOI":"10.4049\/jimmunol.1100491","article-title":"Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis","volume":"187","author":"Morigi","year":"2011","journal-title":"J Immunol"},{"key":"10.1111\/jth.13964_bb0105","doi-asserted-by":"crossref","first-page":"6394","DOI":"10.4049\/jimmunol.0900151","article-title":"Shiga toxin activates complement and binds factor H: evidence for an active role of complement in hemolytic uremic syndrome","volume":"182","author":"Orth","year":"2009","journal-title":"J Immunol"},{"key":"10.1111\/jth.13964_bb0110","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.molimm.2013.11.009","article-title":"Interaction of Shiga toxin 2 with complement regulators of the factor H protein family","volume":"58","author":"Poolpol","year":"2014","journal-title":"Mol Immunol"},{"key":"10.1111\/jth.13964_bb0115","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1128\/IAI.01079-12","article-title":"Shiga toxin 2 reduces complement inhibitor CD59 expression on human renal tubular epithelial and glomerular endothelial cells","volume":"81","author":"Ehrlenbach","year":"2013","journal-title":"Infect Immun"},{"key":"10.1111\/jth.13964_bb0120","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1172\/JCI0212119","article-title":"Thrombin\u2010activatable fibrinolysis inhibitor (TAFI) deficiency is compatible with murine life","volume":"109","author":"Nagashima","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1111\/jth.13964_bb0125","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/1756-0500-7-233","article-title":"A robust scoring system to evaluate sepsis severity in an animal model","volume":"7","author":"Shrum","year":"2014","journal-title":"BMC Res Notes"},{"key":"10.1111\/jth.13964_bb0130","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.4049\/jimmunol.1102118","article-title":"Lack of the lectin\u2010like domain of thrombomodulin worsens Shiga toxin\u2010associated hemolytic uremic syndrome in mice","volume":"189","author":"Zoja","year":"2012","journal-title":"J Immunol"},{"key":"10.1111\/jth.13964_bb0135","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1002\/art.10591","article-title":"Mechanisms of effects of complement inhibition in murine collagen\u2010induced arthritis","volume":"46","author":"Banda","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1111\/jth.13964_bb0140","first-page":"6.15","article-title":"Whole blood analysis of leukocyte\u2010platelet aggregates","volume":"78","author":"Gerrits","year":"2016","journal-title":"Curr Protoc Cytom"},{"key":"10.1111\/jth.13964_bb0145","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1681\/ASN.2006050419","article-title":"A murine model of HUS: Shiga toxin with lipopolysaccharide mimics the renal damage and physiologic response of human disease","volume":"17","author":"Keepers","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/jth.13964_bb0150","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1160\/TH12-04-0273","article-title":"Fibrinogen gene regulation","volume":"108","author":"Fish","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13964_bb0155","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1161\/ATVBAHA.109.202259","article-title":"Enhanced abdominal aortic aneurysm formation in thrombin\u2010activatable procarboxypeptidase B\u2010deficient mice","volume":"30","author":"Schultz","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.13964_bb0160","doi-asserted-by":"crossref","first-page":"5503","DOI":"10.1182\/blood-2010-09-309161","article-title":"Complement activation on platelet\u2010leukocyte complexes and microparticles in enterohemorrhagic Escherichia coli\u2010induced hemolytic uremic syndrome","volume":"117","author":"Stahl","year":"2011","journal-title":"Blood"},{"key":"10.1111\/jth.13964_bb0165","doi-asserted-by":"crossref","first-page":"8955","DOI":"10.1073\/pnas.92.19.8955","article-title":"Anti\u2010C5 monoclonal antibody therapy prevents collagen\u2010induced arthritis and ameliorates established disease","volume":"92","author":"Wang","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1111\/jth.13964_bb0170","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.toxicon.2010.04.007","article-title":"Cobra venom factor: Structure, function, and humanization for therapeutic complement depletion","volume":"56","author":"Vogel","year":"2010","journal-title":"Toxicon"},{"key":"10.1111\/jth.13964_bb0175","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1182\/blood-2016-11-709865","article-title":"HUS and atypical HUS","volume":"129","author":"Jokiranta","year":"2017","journal-title":"Blood"},{"key":"10.1111\/jth.13964_bb0180","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ebiom.2016.02.011","article-title":"Complement activation in arterial and venous thrombosis is mediated by plasmin","volume":"5","author":"Foley","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1111\/jth.13964_bb0185","doi-asserted-by":"crossref","first-page":"18831","DOI":"10.1074\/jbc.M111.323287","article-title":"Plasminogen is a complement inhibitor","volume":"287","author":"Barthel","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.13964_bb0190","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1055\/s-0036-1592302","article-title":"Plasmin(ogen) at the nexus of fibrinolysis, inflammation, and complement","volume":"43","author":"Foley","year":"2017","journal-title":"Semin Thromb Hemost"},{"key":"10.1111\/jth.13964_bb0195","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1074\/jbc.M805000200","article-title":"Regulation of chemerin bioactivity by plasma carboxypeptidase N, carboxypeptidase B (activated thrombin\u2010activable fibrinolysis inhibitor), and platelets","volume":"284","author":"Du","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.13964_bb0200","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/ndt\/gft470","article-title":"Outbreak of Escherichia coli O104:H4 haemolytic uraemic syndrome in France: outcome with eculizumab","volume":"29","author":"Delmas","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/jth.13964_bb0205","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2146\/ajhp140134","article-title":"Safe and effective use of eculizumab in the treatment of severe Shiga toxin Escherichia coli\u2010associated hemolytic uremic syndrome","volume":"72","author":"Dinh","year":"2015","journal-title":"Am J Health Syst Pharm"},{"key":"10.1111\/jth.13964_bb0210","doi-asserted-by":"crossref","first-page":"e1000","DOI":"10.1097\/MD.0000000000001000","article-title":"Eculizumab in typical Hemolytic Uremic Syndrome (HUS) with neurological involvement","volume":"94","author":"Pape","year":"2015","journal-title":"Medicine"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.13964","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.13964","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jth.13964","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622010637?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622010637?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.13964","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:21:17Z","timestamp":1761535277000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622010637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S1538783622010637"],"URL":"https:\/\/doi.org\/10.1111\/jth.13964","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Carboxypeptidase B2 and N play different roles in regulation of activated complements C3a and C5a in mice","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.13964","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2018 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}